Related Experiment Video

Updated: Apr 19, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.7K

Neonatal hemolysis and risk of bilirubin-induced neurologic dysfunction

Ronald J Wong1, David K Stevenson1

  • 1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

Seminars in Fetal & Neonatal Medicine
|January 7, 2015
PubMed

Insights

Severe hyperbilirubinemia in newborns, often caused by hemolysis, increases the risk of bilirubin-induced neurologic dysfunction (BIND). Early identification of high-risk infants using novel technologies is crucial to prevent long-term neurologic damage.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Hematology

Background:

  • Severe hyperbilirubinemia in newborns results from excessive bilirubin production or impaired conjugation.
  • This condition elevates the risk of bilirubin-induced neurologic dysfunction (BIND).
  • Infants with increased bilirubin production due to hemolysis are at the highest risk.

Purpose of the Study:

  • To highlight the significance of identifying infants at risk for severe hyperbilirubinemia.
  • To emphasize the role of hemolysis and its exacerbating factors in neonatal jaundice.
  • To underscore the importance of novel technologies in preventing BIND.

Main Methods:

  • Review of existing literature on neonatal hyperbilirubinemia.
  • Analysis of causes of severe hemolysis in newborns.
  • Discussion of the impact of perinatal sepsis and genetic factors.

Main Results:

  • Severe hemolysis, driven by immune and non-immune conditions, is a primary cause of high bilirubin levels.
  • Perinatal sepsis and genetic predispositions can worsen hemolysis and hyperbilirubinemia.
  • BIND is a significant risk associated with severe neonatal jaundice.

Conclusions:

  • Identifying infants with severe hyperbilirubinemia and high hemolysis rates is critical.
  • Novel diagnostic technologies are essential for early detection and intervention.
  • Preventing BIND reduces the incidence of long-term neurologic sequelae in affected infants.

Keywords:
Carbon monoxideHyperbilirubinemiaJaundiceKernicterus

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K
Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

1.2K

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
2
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
4
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.6K
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
3
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K